UBS Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,430
| Closed | -$56K | – | 8619 |
|
|
2020
Q4 | $56K | Sell |
2,430
-65,731
| -96% | -$1.51M | ﹤0.01% | 5099 |
|
|
2020
Q3 | $694K | Sell |
68,161
-4,727
| -6% | -$48.1K | ﹤0.01% | 3164 |
|
|
2020
Q2 | $1.09M | Sell |
72,888
-1,652
| -2% | -$24.6K | ﹤0.01% | 2762 |
|
|
2020
Q1 | $908K | Sell |
74,540
-2,224
| -3% | -$27.1K | ﹤0.01% | 2742 |
|
|
2019
Q4 | $1.22M | Buy |
+76,764
| New | +$1.22M | ﹤0.01% | 3170 |
|
|
2019
Q3 | – | Sell |
-10,485
| Closed | -$138K | – | 3229 |
|
|
2019
Q2 | $138K | Buy |
+10,485
| New | +$138K | ﹤0.01% | 4334 |
|